Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| J07AL02 | PNEUMOSIL (10-VALENT) | G | Pneumococcal polysaccharide conjugate vaccine (adsorbed) - | Injectable suspension | 3386483.1 | |
| J07AL02 | PREVENAR 20 | B | Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) - | Injectable suspension | 7415106.7725 | |
| J07AL02 | VAXNEUVANCE | B | Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant - | Injectable suspension | 6988412.9091 | |
| J07AL01 | PNEUMOVAX 23 | B | Polysaccharides from each of 23 capsular types of Streptococcus pneumoniae - 25mcgx23serotypes/0.5ml | Injectable solution | 2378601.225 | |
| J07AJ51 | BOOSTRIX | B | Diphteria toxoid purified - ≥2.5Lf/0.5ml, Tetanus toxoid purified - ≥5Lf/0.5ml, Bordetella Pertussis Antigens: toxoid - 8mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 8mcg/0.5ml, Pertactine - 2.5mcg Al3+/0.5ml, Aluminium hydroxide - 0.3mg Al3+/0.5ml, Aluminium Phosphate - 0.2mg/0.5ml | Injectable suspension | 1394908.515 | |
| J07AH08 | MENACTRA MENINGOCOCCAL POLYSACCHARIDE DIPHTERIA TOXOID CONJUGATE VACCINE | B | Meningococcal Polysaccharides (serogroups A, C, Y and W-135) - 4mcg/0.5ml each, Diphteria Toxoid Protein - 48mcg/0.5ml | Injectable solution | 6144047.91 | |
| J07AH08 | NIMENRIX | B | Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml | Injectable lyophilised powder for solution+diluent | 4483058.58 | |
| J07AH08 | MENQUADFI | G | Meningococcal (serogroups A, C, W and Y) conjugate vaccine - | Injectable solution | 4859334.48 | |
| J07AH | MENFIVE | G | Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine - | Injectable freeze dried powder + diluent | 3527586.5625 | |
| J06BD01 | SYNAGIS | BioTech | Palivizumab - 100mg/ml | 100mg/ml | Injectable solution | 57429464.463 |
| J06BD01 | SYNAGIS | BioTech | Palivizumab - 50mg/0.5ml | 50mg/0.5ml | Injectable solution | 38316692.8872 |
| J06BB05 | RABISHIELD-100 (RABIES HUMAN MONOCLONAL ANTIBODY rDNA) | BioHuman | Rabies, Human IgG1 Monoclonal Antibody - 100IU/2.5ml | 100IU/2.5ml | 8455823.5125 | |
| J06BB04 | IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB | BioHuman | Hepatitis B immunoglobulin (human) - 100UI/ml | 100UI/ml | Injectable solution | 6853730.4656716 |
| J06BB04 | IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB | BioHuman | Hepatitis B immunoglobulin (human) - 500UI/5ml | 500UI/5ml | Injectable solution | 26599934.9952 |
| J06BB02 | TETAGAM P | BioHuman | Human Tetanus Immunoglobulin - 250IU/ml | 250IU/ml | Injectable solution | 3075475.484081 |
| J06BB02 | TETANUS GAMMA | BioHuman | Human Tetanus Immunoglobulin - 250IU/ml | 250IU/ml | Injectable solution | 3077399.325 |
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
